Friday, 8 October 2021
Lack of evidence is key barrier to using portable devices to detect poor quality medicines
A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.
Tuesday, 21 September 2021
New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease
A new study suggests there are important but neglected issues with substandard and falsified (SF*) medicines and medical products used to prevent and treat cardiovascular diseases.
Monday, 20 September 2021
Open call to join new studies launched by the VL research community
Two new Study Groups, a collaboration between IDDO and the global visceral leishmaniasis (VL) research community, have been formed to answer specific research questions about treatments. They will undertake individual patient data meta-analyses using datasets from multiple studies, across sub-popula...
Thursday, 2 September 2021
IDDO to share latest research at ECTMIH 2021
Join the IDDO team who will be presenting at the 12th European Congress on Tropical Medicine and International Health (ECTMIH) between 28 September to 1 October. ECTMIH provides a platform for experts, scientists and researchers to present scientific developments and breakthroughs in tropical medici...
Wednesday, 11 August 2021
The scale of the problem of VL in pregnancy is underestimated
A new systematic review published today in PLOS Neglected Tropical Diseases has found that reports on the occurrence of Visceral Leishmaniasis (VL) in pregnant women are rare in published literature, are not systematically captured, and cases are rarely followed-up to detect the consequences of infe...
Thursday, 29 July 2021
Preprints: it’s time to agree on terminology and best practice
Preprints are increasingly being used to share manuscripts that are not yet peer-reviewed to enable the rapid dissemination of research findings. In particular, they have also become an important source of information for wider, non-specialist audiences keen to follow COVID-19 research developments,...
Friday, 23 July 2021
Track regulatory and WHO alerts on our substandard and falsified medical products tool
Substandard and falsified (SF*) medical products, including medicines, vaccines, diagnostic tests and medical devices are critical global public health issues and current SF surveillance in most of the world is extremely limited. Information sharing on SF incidents is very poor. Our Medicine Quality...
Thursday, 20 May 2021
Join IDDO at this year’s BSP Conference in June
This year’s BSP Conference will run across two streams: the usual science stream with its mix of varied high quality themed scientific sessions, keynote speakers and presentations by postgraduate and postdoctoral researchers, and a second, specialist stream which will include a series of talks from ...
Tuesday, 27 April 2021
ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination
27 APRIL 2021 – The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.
Monday, 29 March 2021
Risks of serious adverse events following treatment for visceral leishmaniasis
The results of a large-scale systematic review and meta-analysis have published in PLOS Neglected Tropical Diseases. This research aimed to collate all reported serious adverse events (SAE) in visceral leishmaniasis (VL) clinical trials and quantify the incidence of mortality during the first 30 day...
Monday, 29 March 2021
Calls for clarity on pooled evidence in COVID-19 therapeutic reviews and guidelines
IDDO’s Director, Professor Philippe Guérin, has co-authored a letter published in The Lancet drawing attention of the risk of pooling data from uncomplicated illness and more severe ill hospitalised patients in the development of COVID-19 treatment guidelines. Although SARS-CoV-2 is one virus, the C...
Thursday, 18 March 2021
Researchers call for access to Ivermectin for young children
Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network (WWARN)’s new meta-analysis published today provides evi...
Wednesday, 17 March 2021
Gender imbalance in visceral leishmaniasis clinical trials
Researchers have found that despite an ongoing trend for a decreasing proportion of males being enrolled in antileishmanial therapeutic efficacy trials over time, there are still 1.8 times as many males as females involved in clinical trials. A new systematic review and meta-analysis published today...
Tuesday, 16 March 2021
New report highlights growing concern of vaccine falsification
The Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccine...
Friday, 26 February 2021
Applications for RSTMH 2021 grants open
The small grants programme offers early career researchers and global health professionals based anywhere in the world the opportunity to apply for funding in a topic related to tropical medicine and global health. The programme funds projects across the research spectrum, including lab-based, clini...
Friday, 12 February 2021
Evidence supports WHO recommendation for PQ combined with ACTs to block Plasmodium falciparum transmission
Evidence from a new study, initiated by the Primaquine Roll Out Group and conducted at WWARN, supports the World Health Organization (WHO) recommendation for use of 0.25mg/kg dose of primaquine (PQ) combined with artemisinin-based combination therapies (ACT) to block Plasmodium falciparum transmissi...
Thursday, 4 February 2021
Geneva Health Forum panel on the elimination of NTDs and the new WHO Roadmap
The WHO 2030 NTD Roadmap has just been launched and a recent Geneva Health Forum panel took that as its starting point to discuss the possibility of eliminating neglected tropical diseases (NTDs). IDDO’s Director, Professor Philippe Guérin joined co-panellists Dr Amy Fall, the Global Health Medi...
Wednesday, 13 January 2021
Check-list recommended to improve reporting of microscopy methods and results in malaria studies
A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.
Wednesday, 2 December 2020
Tribute to the Memory of Prof. P. Claver Kayumba, University of Rwanda
It is with great sadness that IDDO has learnt of the death of Professor P. Claver Kayumba, who latterly coordinated academic and professional education programs at the EAC Regional Center of Excellence for Vaccines, Immunization and Health Supply Chain Management (RCE-VIHSCM), hosted by the Universi...